Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Varicose Veins Treatment Market size was valued at USD 4.3 billion in 2024 and is anticipated to reach USD 7.8 billion by the end of 2037, registering at a CAGR of 7.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of varicose veins treatment is assessed at USD 4.3 billion.
The market development is projected to be substantial, affecting approximately 30.5% of the adult population worldwide, owing to venous insufficiency in varicose veins and the incidence of chronic venous disorder (CVD). For instance, as stated in the 2023 CDC report, more than 41 million adults in the U.S. suffer from venous diseases, out of which 3 million new cases are diagnosed every year. Besides, the need for treatment is another driving factor for the market, which is further amplified by the rising aging population, that is almost 21% of adults over 60 years of age exhibit symptomatic venous reflux. Also, minimally invasive treatments, including sclerotherapy and endovenous laser ablation (EVLA) are suitable to overcome the disorder.
Furthermore, the aspect of the supply chain system is yet another factor for uplifting the market across different nations. This system relies on the international network that comprises specialty clinics, medical device manufacturers, and active pharmaceutical ingredient suppliers. A few APIs suitable for sclerotherapy agents include sodium tetradecyl sulfate (STS) and polidocanol, which are mainly sourced from China, India, and Germany, accounting for approximately 67% of the overall production. Besides, the availability of medical devices such as venous closure systems and laser fibers, manufactured in Japan, Ireland, and the U.S., account for 42% of imported components, thus driving the market growth.
